• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Celsion Corp. (CLSN)

    -NasdaqCM
    2.21 Up 0.01(0.45%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:2.20
    Open:2.20
    Bid:N/A
    Ask:2.65 x 1200
    1y Target Est:7.00
    Beta:1.01
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.18 - 2.28
    52wk Range:2.15 - 4.03
    Volume:29,602
    Avg Vol (3m):71,481
    Market Cap:44.15M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLSN

    Comparison

    Symbol% ChgMkt Cap
    CLSNUp 0.45%44.15M
    BSDMDown 9.47%12.11M
    DCTHDown 2.36%11.72M
    MMSIDown 1.79%665.35M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):87.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.42
    Quarterly EPS Est (Dec-14) :-0.36
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback